It didn’t come from either, it came from me, as a benchmark for what seems conservatively possible to achieve in the near-term, and for the size of impact necessary to be plausibly cost-competitive with other causes like global poverty. (If the same amount of funding yielded only one year’s delay in the DALY burden of age-related diseases, I think that would make global poverty likely to be a “better buy.”)
It didn’t come from either, it came from me, as a benchmark for what seems conservatively possible to achieve in the near-term, and for the size of impact necessary to be plausibly cost-competitive with other causes like global poverty. (If the same amount of funding yielded only one year’s delay in the DALY burden of age-related diseases, I think that would make global poverty likely to be a “better buy.”)